Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 3, 2000, Pages 375-377

  Giacometti, A ^b   Cirioni, O ^a   Barchiesi, F ^b   Scalise, G ^b  

^a Azienda Ospedaliera Umberto I   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; LASALOCID; RANALEXIN;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL COUNT; CONTROLLED STUDY; CRYPTOSPORIDIUM PARVUM; CULTURE MEDIUM; NONHUMAN;

EID: 0034007516     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.3.375     Document Type: Article

References (10)

1. Woods, K. M., Nesterenko, M. V. & Upton, S. J. (1996). Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro. Annals of Tropical Medicine and Parasitology 90, 603-15.
2. Hancock, R. E. & Chapple, D. S. (1999). Peptide antibiotics. Antimicrobial Agents and Chemotherapy 43, 1317-23.
3. Clark, D. P., Durell, S., Maloy, W. L. & Zasloff, M. (1994). Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic polymyxin. Journal of Biological Chemistry 269, 10849-55.
4. Rehg, J. E. (1994). A comparison of anticryptosporidial activity of paromomycin with that of other aminoglycosides and azithromycin in immunosuppressed rats. Journal of Infectious Diseases 170, 934-8.
5. Blanshard, C., Shanson, D. C. & Gazzard, B. G. (1997). Pilot studies of azithromycin, letrazuril and paromomycin in the treatment of cryptosporidiosis. International Journal of Sexual Transmitted Diseases and AIDS 8, 124-9.
6. Oz, H. S., Hughes, W. T. & Rehg, J. E. (1997). Efficacy of lasalocid against murine Pneumocystis carinii pneumonitis. Antimicrobial Agents and Chemotherapy 41, 191 -2.
7. Schwingel, W. R., Bates, D. B., Denham, S. C. & Beede, D. K. (1989). Lasalocid-catalyzed proton conductance in Streptococcus bovis as affected by extracellular potassium. Applied and Environmental Microbiology 55, 259-60.
8. Arrowood, M. J., Jaynes, J. M. & Healey, M. C. (1991). In vitro activities of lytic peptides against the sporozoites of Cryptosporidium parvum. Antimicrobial Agents and Chemotherapy 35, 224-7.
9. Vaara, M. & Porro, M. (1996). Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria. Antimicrobial Agents and Chemotherapy 40, 1801-5.
10. Viljanen, P., Matsunaga, H., Kimura, Y. & Vaara, M. (1991). The outer membrane permeability-increasing action of deacylpolymyxins. Journal of Antibiotics 44, 517-23.